Up a level
Export as
Group by: Author/Creator | Item Type
Jump to: A | B | D | G | H | L | M | O | P | R | S | V | W | Z
Number of items at this level: 122.

A

Arts, Danielle; Habl, Claudia; Leopold, Christine; Windisch, Friederike (2007): PPRI Pharma Profile. Austria 2007. Gesundheit Österreich GmbH / Geschäftsbereich ÖBIG, Wien.

Arts, Danielle; Habl, Claudia; Schnabel, Eva (2006): Nahtstellenmanagement bei Arzneimitteln. Gesundheit Österreich GmbH / Geschäftsbereich ÖBIG, Wien.

B

Benslaoui, Bouchra; Zerhouni, Mohammed Wadie; Chikhaoui, Anas; Fouila, Fatima Zahra Ben; Habimana, Katharina; Hachri, Hafid; Bigdeli, Maryam; Vogler, Sabine; Taoufik, Jamal; Nejmi, Hicham (2019): Regulating medicine prices in Morocco - Effects of the medicine price decree 2014 on medicine prices. Journal of Pharmaceutical Policy and Practice. ISSN 2052-3211

Bouvy, Jacoline; Vogler, Sabine (2013): Priority Medicine Report. Update on 2004 Background Paper 8.3. Pricing and Reimbursement Policies: Impacts on Innovation. In: UNSPECIFIED (ed.): Priority Medicines for Europe and the World "A Public Health Approach to Innovation". WHO, Wien.

D

Dedet, Guillaume; Polton, Dominique; Zimmermann, Nina; Habl, Claudia; Bak Pedersen, Hanne (2019): Evaluation of the Affordable Medicines Programme in Ukraine. WHO Regional Office for Europe, Kopenhagen.

G

Gamba, Simona; Pertile, Paolo; Vogler, Sabine (2020): The impact of managed entry agreements on pharmaceutical prices. Health Economics. ISSN https://doi.org/10.1002/hec.4112

Gombocz, Margit (2019): Public spending on orphan medicines: a review of the literature. 4. Konferenz der Austrian Health Economics Association (ATHEA), 1. März 2019, Wien.

H

Haasis, Manuel Alexander; Schneider, Peter (2018): A Review of price studies for generic and biosimilar medicines. EUHEA Conference, 12. Juli 2018, Maastricht.

Habl, Claudia (2018): Assessment of the “Affordable Medicines” program: qualitative findings. Policy Dialogue “Affordable medicines” programme: results and recommendation for progress towards Universal Health Coverage, 18. Oktober 2018, Kiew.

Habl, Claudia (2018): EURIPID Collaboration Current state of play & Technical Guidance Document on External Reference Pricing. Network of Competent Authority of Pricing and Reimbursement (NCAPR) meeting, 26. September 2018, Wien.

Habl, Claudia (2018): Euripid State of Play. EFPIA Working Group on Access to Medicines, 3. Mai 2018, Brüssel.

Habl, Claudia (2018): Main Principles of External Reference Pricing. EU Euripid EU-Stakeholder Meeting, 23. März 2018, Brüssel.

Habl, Claudia; Antony, Katja; Arts, Danielle; Entleitner, Michael; Fröschl, Barbara; Leopold, Christine; Stürzlinger, Heidi; Vogler, Sabine; Weigl, Marion (2006): Surveying, Assessing and Analysing the Pharmaceutical Sector in the 25 EU Member States. Gesundheit Österreich GmbH / Geschäftsbereich ÖBIG, Wien.

Habl, Claudia; Bachner, Florian (2011): EMINET. Initial investigation to assess the feasibility of a coordinated system to access orphan medicines. Gesundheit Österreich GmbH / Geschäftsbereich ÖBIG, Wien.

Habl, Claudia; Németh, Gergely; Schneider, Peter (2019): How the Euripid Collaboration contributes to the affordability of medicines in Europe. Journal of Pharmacy Policy and Practice, 12 (3). ISSN 2052-3211

Habl, Claudia; Schneider, Peter; Németh, Gergely; Šebesta, Robin (2018): Euripid Collaboration Guidance Principles for External Reference Pricing in Europe. Track Health systems and health care. European Public Health Conference 2018, 29. November 2018, Ljubliana.

Habl, Claudia; Schneider, Peter; Németh, Gergely; Šebesta, Robin (2018): Euripid Collaboration Guidance Principles for External Reference Pricing in Europe. Track Health systems and health care. The European Journal of Public Health, 28 (4).

Habl, Claudia; Schneider, Peter; Németh, Gergely; Šebesta, Robin (2018): Euripid Guidance Document on External Reference Pricing (ERP). European Commission, Consumer, Health and Food Executive Agency (Chafea), Brussels.

Habl, Claudia; Vogler, Sabine; Leopold, Christine; Schmickl, Bettina; Fröschl, Barbara (2008): Referenzpreissysteme in Europa. ÖBIG Forschungs- und Planungsgesellschaft mbH, Wien.

L

Leopold, Christine; Habl, Claudia; Morak, Simone; Rosian-Schikuta, Ingrid; Vogler, Sabine (2008): Leistungsfähigkeit des österreichischen Gesundheitssystems im Vergleich. Gesundheit Österreich GmbH / Geschäftsbereich ÖBIG, Wien.

Leopold, Christine; Habl, Claudia; Rosian-Schikuta, Ingrid (2008): Steuerung des Arzneimittelverbrauchs am Beispiel Dänemark. Gesundheit Österreich GmbH / Geschäftsbereich ÖBIG, Wien.

Leopold, Christine; Habl, Claudia; Vogler, Sabine; Morak, Simone (2008): PPRI-Pharma-Profil. Österreich 2008. Gesundheit Österreich GmbH / Geschäftsbereich ÖBIG, Wien. ISBN 3-85159-121-6

Leopold, Christine; Rovira, Joan; Habl, Claudia (2010): EMINET. Generics in small markets or for low volume medicines. Gesundheit Österreich GmbH / Geschäftsbereich ÖBIG, Wien.

M

Mardetko, Nika; Kos, Mitja; Vogler, Sabine (2018): Review of studies reporting actual prices for medicines. Expert review of pharmacoeconomics & outcomes research.

Morak, Simone; Vogler, Sabine; Walser, Sabine; Kijlstra, Nico (2010): The pharmaceutical system of the Netherlands and Applying it in Practice. Gesundheit Österreich GmbH / Geschäftsbereich ÖBIG, Wien.

O

Ostermann, Herwig; Bobek, Julia; Renner, Anna; Schneider, Peter; Vogler, Sabine (2016): A cost/benefit analysis of self-care initiatives in the European Union – Who’s better off, who’s worse off? EuHEA Conference 2016, 14. Juli 2016, Hamburg.

Ostermann, Herwig; Windisch, Friederike (2019): Herausforderungen für Medizinprodukte. Registrierung schafft Sicherheit. Das Medizinprodukt, 2019 (2). pp. 20-22.

P

Panteli, Dimitra; Arickx, Francis; Cleemput, Irina; Dedet, Guillaume; Eckhardt, Helene; Fogarty, Emer; Gerkens, Sophie; Henschke, Cornelia; Hislop, Jennifer; Jommi, Claudio; Kaitelidou, Daphne; Kawalec, Pawel; Keskimäki, Ilmo; Kroneman, Madelon; Bastida, Julio Lopez; Barros, Pedro Pita; Ramsberg, Joakim; Schneider, Peter; Spillane, Susan; Vogler, Sabine; Vuorenkoski, Lauri; Kildemoes, Helle Wallach; Wouters, Olivier; Busse, Reinhard (2016): Pharmaceutical regulation in 15 European countries. Review. European Observatory on Health Systems and Policies.

R

Rintoul, Andrew; Colbert, Allison; Garner, Sarah; Kotwani, Anita; Vogler, Sabine; Bouvy, Jacoline; Hill, Andrew (2020): Medicines with one seller and many buyers: strategies to increase the power of the payer. BMJ, 369 (m1705).

Rosian-Schikuta, Ingrid; Antony, Katharina; Habl, Claudia; Vogler, Sabine; Weigl, Marion (2001): Benchmarking Arzneimittelausgaben. Strategien zur Kostendämpfung in der Europäischen Union. Gesundheit Österreich GmbH / Geschäftsbereich ÖBIG, Wien. ISBN 3-85159-025-2

Rosian-Schikuta, Ingrid; Mildschuh, Stephan; Vogler, Sabine; Winkler, Petra; Antony, Katja (2002): Selbstbeteiligung. Internationaler Vergleich und Implikationen für Österreich. Gesundheit Österreich GmbH / Geschäftsbereich ÖBIG, Wien.

S

Schneider, Peter (2018): Das Österreichische Arzneimittelsystem (im Vergleich zu Deutschland). Studienbesuch FH Ostfalia, 19. September 2018, Ostfalia.

Schneider, Peter (2019): Entwicklungen in Europa zu Preisbildung und Erstattung. imh-Konferenz "Biosimilar", 20. März 2019, Wien.

Schneider, Peter (2019): External Price Referencing (EPR) - Practice and challenges. Meeting of the Nordic Council, 15. Mai 2019, Webinar.

Schneider, Peter (2020): How much can biosimilars contribute to savings in the German health system? 5. Konferenz der Austrian Health Economics Association (ATHEA), 28. Februar 2020, Wien.

Schneider, Peter (2016): Pharmaceutical pricing and reimbursement reform in Kyrgyzstan. WHO Regional Office for Europe, Copenhagen. ISBN 9789289052191

Schneider, Peter (2018): Pharmacy Reimbursement I – Overview European Systems. EU Ratspräsidentschaft, CAPR Meeting, 26. September 2018, Brüssel.

Schneider, Peter (2019): There is no such thing as a biosimilar patent cliff?!? - An analysis of price development of biological medicines after patent expiration. 4. Konferenz der Austrian Health Economics Association (ATHEA), 1. März 2019, Wien.

Schneider, Peter; Habl, Claudia; Németh, Gergely (2019): Ex-post analysis of medicines subject to Managed-Entry-Agreements (MEAs) – a feasible approach for monitoring and price analyses. 4. International PPRI Conference 2019: Medicine access challenge - The value of pricing and reimbursement policies, 24. Oktober 2019, Wien.

Schneider, Peter; Vogler, Sabine; Zimmermann, Nina; Zuba, Martin (2018): Preisvergleich ausgabenstarker Arzneispezialitäten 2017. Gesundheit Österreich, Wien.

Schneider, Peter; Zimmermann, Nina; Lepuschütz, Lena; Vogler, Sabine (2019): Estimating price developments of biological medicines during market exclusivity. 4. International PPRI Conference 2019: Medicine access challenge - The value of pricing and reimbursement policies, 24. Oktober 2019, Wien.

V

Vogler, Sabine (2019): 10 Jahre Pharma-Plattform - Präsentation der Ergebnisse der Stakeholder-Befragung. Pharma-Plattform, 11. September 2019, Wien.

Vogler, Sabine (2018): Access to High-Cost Medicines in Europe. In: Zaheer-Ud-Din, Babar (ed.): Equitable Access to High-Cost Pharmaceuticals. Elsevier, pp. 143-164.

Vogler, Sabine (2018): Addressing high drug prices: What can be learned from European policies? Knowledge Network for Innovation and Access to Medicines. Graduate Institute of Geneva, 13. Dezember 2018, Webinar.

Vogler, Sabine (2018): Biosimilars: Entwicklungen in Europa. Preisbildung und Erstattungssituation. imh Fachkonferenz Biosimilars, 31.Jänner 2018, Vienna.

Vogler, Sabine (2019): Comparative analysis of pharmaceutical pricing and reimbursement policies in 47 countries. 24. Jahreskonferenz der Italian Health Economics Association (AIES), 3. Oktober 2019, Pisa.

Vogler, Sabine (2019): Fair Prices for medicines? Exploring competent authorities and public payers preferences on pharmaceutical policies. Empirica - Journal of European Economics, 46 (3). pp. 443-469.

Vogler, Sabine (2018): Fair prices for medicines? Exploring competent authorities’ and Public Payers’ preferences on pharmaceutical policies. Annual Meeting & 100th Anniversary of the Austrian Economic Association (NOeG), 12. Mai 2018, Wien.

Vogler, Sabine (2018): Financial burden of co-payment for outpatient medicines in European countries. EuHEA (European Health Association) Conference, 12. Juli 2018, Maastricht.

Vogler, Sabine (2019): How does real world evidence impact decision-making now and in the future: Using RWD/RWE to improve affordable access to medicines. Joint Meeting of the Health and Pharmaceutical Sector Chief Officers, 27. September 2019, Helsinki.

Vogler, Sabine (2018): How to redesign pricing, reimbursement and procurement? Policy brief on ensuring access to medicines. Network of Competent Authority of Pricing and Reimbursement (NCAPR) meeting, 26. September 2018, Vienna.

Vogler, Sabine (2019): Il miglioramento dei processi, la cooperazione, l’evidenza e la trasparenza: i temi chiave per le proposte di riforma delle politiche sul prezzo e rimborso dei farmaci. Politiche Sanitarie, 20 (4). pp. 180-182. ISSN 2038-1832

Vogler, Sabine (2019): Improving access to HIV, Hep C and TB medicines - Which role do pricing policies play? AIDS Action Europe, 21. Juni 2019, Webinar.

Vogler, Sabine (2014): Liberalization in the Pharmacy Sector. OECD Global Forum on Distribution, Paris.

Vogler, Sabine (2019): Managed Entry Agreements (MEA) and their confidentiality across Europe. Convegno Nazionale "Econonomia & Politica del Farmaco e delle Tecnologie Sanitarie", 28. Juni 2019, Mailand.

Vogler, Sabine (2018): Managing the Next Decade in Cancer. Innovation meets Growing Inequalities. World Health Summit 2018, 14. Oktober 2018, Berlin.

Vogler, Sabine (2018): Medicines reimbursement policies in Europe. IADB (Inter-American Development Bank), 24. Oktober 2018, Webinar.

Vogler, Sabine (2019): Medicines shortages (non-accessibility of medicines) - from the perspective of pharmaceutical pricing and reimbursement policies. Treffen des COST ACTION CA15105 (European Medicines Shortages Research Network), 13. März 2019, Leuven.

Vogler, Sabine (2019): Nutzenbewertung / Health Technology Assessment (HTA) von Arzneimitteln im Spannungsfeld zwischen Zulassung und Preisbildung - Europavergleich. Krankenhaus-Pharmazie Update, 24. Mai 2019, Wien.

Vogler, Sabine (2019): Pharmaceutical Policies for Better Access to Medicines. WHO Barcelona Course on Health Financing for Universal Health Coverage, 19. März 2019, Barcelona.

Vogler, Sabine (2019): Preisregulierung für neue Arzneimittel (mit Zusatznutzen) - Perspektiven und Lösungsansätze. Expertengespräch mit der AOK, 12. Juni 2019, Berlin.

Vogler, Sabine (2019): Research study on impact and benefits of cross-country collaboration in the European region. 4. Konferenz der Austrian Health Economics Association (ATHEA), 1. März 2019, Wien.

Vogler, Sabine (2018): Shining some light on confidential arrangements Relevance of discounts for pharmaceutical pricing in European countries. EbM-Kongress, 9. März 2018, Graz.

Vogler, Sabine (2019): Strategies for containing costs of expensive new pharmaceuticals - Experience from European countries. 8th Meeting of the OECD Joint Network of Senior Budget and Health Officials, 11. Februar 2019, Paris.

Vogler, Sabine (2019): What are the real impacts & benefits of cross-border collaborations? Findings from research. World Orphan Drug Congress Europe, 14. November 2019, Barcelona.

Vogler, Sabine (2019): Zugang zu Medikamenten - Policy Briefs "How to stimulate innovation to meet patients' needs?" und "How to redesign pricing, reimbursement and procurement". Pharma Plattform, 31. Jänner 2019, Wien.

Vogler, Sabine; Antony, Katja; Arts, Danielle; Habl, Claudia; Fröschl, Barbara; Leopold, Christine; Rosian-Schikuta, Ingrid; Stürzlinger, Heidi; Weigl, Marion (2006): Pharmaceutical Systems In The European Union 2006. Gesundheit Österreich GmbH / Geschäftsbereich ÖBIG, Wien.

Vogler, Sabine; Antony, Katja; Habl, Claudia; Leopold, Christine (2005): Arzneimittelsysteme in den neuen EU-Mitgliedstaaten Estland, Lettland, Litauen, Malta, Polen, Slowakei, Slowenien, Tschechische Republik, Ungarn, Zypern. Gesundheit Österreich GmbH / Geschäftsbereich ÖBIG, Wien.

Vogler, Sabine; Arts, Danielle; Habl, Claudia (2006): Community Pharmacy In Europe. Lessons from deregulation – case studies. Gesundheit Österreich GmbH / Geschäftsbereich ÖBIG, Wien.

Vogler, Sabine; Arts, Danielle; Sandberger, Katharina (2012): Impact of pharmacy deregulation and regulation in European countries. Gesundheit Österreich Forschungs- und Planungs GmbH, Wien.

Vogler, Sabine; Bak Pedersen, Hanne; Dedet, Guillaume (2019): Financial Burden of Prescribed Medicines Included in Outpatient Benefits Package Schemes: Comparative Analysis of Co-Payments for Reimbursable Medicines in European Countries. Applied Health Economics and Health Policy volume (17). pp. 803-816.

Vogler, Sabine; Bak Pedersen, Hanne; Dedet, Guillaume; Schneider, Peter (2019): Affordable and equitable access to subsidised outpatient medicines? Analysis of co-payments under the Additional Drug Package in Kyrgyzstan. International Journal for Equity in Health, 18 (89). ISSN 1475-9276

Vogler, Sabine; Fischer, Stefan (2020): Lieferengpässe bei Arzneimitteln: Internationale Evidenz und Empfehlungen für Deutschland. Kurzgutachten. Gesundheit Österreich, Wien.

Vogler, Sabine; Freihoff, Wilhelm (2003): Kostenfaktoren der tierärztlichen Hausapotheke. Gesundheit Österreich GmbH / Geschäftsbereich ÖBIG, Wien. ISBN 3-85159-059-7

Vogler, Sabine; Haasis, Manuel Alexander; Dedet, Guillaume; Lam, Janice; Bak Pedersen, Hanne (2018): Medicines Reimbursement Policies in Europe. WHO Regional Office for Europe. ISBN 9789289053365

WHO Regional Office for Europe (2020): Cross-country collaborations to improve access to medicines and vaccines in the WHO European Region. World Health Organization, Denmark.

Vogler, Sabine; Haasis, Manuel Alexander; Zimmermann, Nina (2019): PPRI Pharma Brief: Austria 2019. Gesundheit Österreich, Wien.

Vogler, Sabine; Habimana, Katharina (2014): Pharmaceutical pricing policies in European countries. Gesundheit Österreich Forschungs- und Planungs GmbH, Wien.

Vogler, Sabine; Habl, Claudia (2003): Arzneimitteldistribution in Skandinavien. Gesundheit Österreich GmbH / Geschäftsbereich ÖBIG, Wien. ISBN 3-85159-060-0

Vogler, Sabine; Habl, Claudia (2000): E-Pharma. Arzneimittelvertrieb im Internet. Kurzfassung. Gesundheit Österreich GmbH / Geschäftsbereich ÖBIG, Wien.

Vogler, Sabine; Habl, Claudia; Kranvogel-Zellermayer, Edith; Rosian-Schikuta, Ingrid (2000): Apothekenleistungen im europäischen Vergleich. Kurzfassung. Gesundheit Österreich GmbH / Geschäftsbereich ÖBIG, Wien.

Vogler, Sabine; Habl, Claudia; Leopold, Christine; Rosian-Schikuta, Ingrid; de Joncheere, Kees; Lyager Thomsen, Trine (2008): PPRI Report. Gesundheit Österreich GmbH / Geschäftsbereich ÖBIG, Wien. ISBN 10 3-85159-104-6

Vogler, Sabine; Kos, Mitja; Mardetko, Nika (2019): Review of studies reporting actual prices for medicines. Expert Review of Pharmacoeconomics & Outcome Research, 19 (2). pp. 159-179.

Vogler, Sabine; Leopold, Christine (2010): Pharmaceutical Country Profile. Austria. Gesundheit Österreich GmbH, Wien.

Vogler, Sabine; Leopold, Christine; Zimmermann, Nina (2011): Hospital Pharma. Arzneimittelmanagement in Krankenanstalten. Kurzbericht. Gesundheit Österreich GmbH, Vienna. ISBN 13 978-3-85159-156-9

Vogler, Sabine; Lepuschütz, Lena; Schneider, Peter; Stühlinger, Verena (2015): Study on enhanced cross-country coordination in the area of pharmaceutical product pricing. Final report. Gesundheit Österreich Forschung- und Planungs GmbH, Wien.

Vogler, Sabine; Paris, Valérie; Panteli, Dimitra (2018): Ensuring access to medicines: How to redesign pricing, reimbursement and procurement? Policy Brief No. 30. World Health Organization, Copenhagen.

Vogler, Sabine; Pertile, Paolo; Gamba, Simona (2019): Impact of managed-entry agreements on medicines list prices. 4. International PPRI Conference 2019: Medicine access challenge - The value of pricing and reimbursement policies, 23. Oktober 2019, Wien.

Vogler, Sabine; Schmickl, Bettina (2010): Rationale Arzneimitteltherapie in Europa. Gesundheit Österreich GmbH / Geschäftsbereich ÖBIG, Wien.

Vogler, Sabine; Schmickl, Bettina; Zimmermann, Nina (2013): Short PPRI / PHIS Pharma Profile. Austria 2013. Gesundheit Österreich GmbH / Geschäftsbereich ÖBIG, Wien.

Vogler, Sabine; Schneider, Peter (2019): Assessing Data Sources for Medicine Price Studies. International Journal of Technology Assessment in Health Care, 35 (2). pp. 106-115.

Vogler, Sabine; Schneider, Peter (2019): Choosing the right medicines for price comparisons - Analysis of prices of pharmaceutical presentations of the same active ingredient. 4. International PPRI Conference 2019: Medicine access challenge - The value of pricing and reimbursement policies, 24. Oktober 2019, Wien.

Vogler, Sabine; Schneider, Peter (2019): Impact of the external price referencing methodology (EPR) on medicine prices – Simulation of existing EPR models. 4. International PPRI Conference 2019: Medicine access challenge - The value of pricing and reimbursement policies, 24. Oktober 2019, Wien.

Vogler, Sabine; Schneider, Peter (2018): Reimbursement for medicines - Similarities and differences of reference price systems in six European countries. EuHEA (European Health Association) Conference, 13. Dezember 2018, Maastricht.

Vogler, Sabine; Schneider, Peter; Panteli, Dimitri; Busse, Reinhard (2019): Biosimilars in Deutschland und im europäischen Vergleich – Entwicklungen und Potenziale. In: Schwabe, U.; Paffrath, D.; Ludwig, WD.; Klauber, J (eds.): Arzneiverordnungs-Report 2019. Springer, Berlin, Heidelberg.

Vogler, Sabine; Schneider, Peter; Zimmermann, Nina (2019): Estimating Real Prices of Medicines used in Hospitals - Study protocol. Gesundheit Österreich, Wien.

Vogler, Sabine; Schneider, Peter; Zimmermann, Nina (2019): Evolution of Average European Medicine Prices: Implications for the Methodology of External Price Referencing. PharmacoEconomics - Open (3). pp. 303-309.

Vogler, Sabine; Schneider, Peter; Zimmermann, Nina (2016): Preisvergleich kostenintensiver Arzneimittel 2015. Gesundheit Österreich GmbH, Wien.

Vogler, Sabine; Schneider, Peter; Zimmermann, Nina (2017): Price comparison of high-cost medicines 2017.Study protocol. Gesundheit Österreich, Vienna.

Vogler, Sabine; Suleman, Fatima (2018): Research study on impact and benefits of cross border collaboration in WHO European Region. INFARMED Conference “Facing the Challenges – Equity, Sustainability and Access, 29. November 2018, Lissabon.

Vogler, Sabine; Van den Ham, Rianne; Haasis, Manuel Alexander; Suleman, Fatima (2019): Together working to improve access to medicines: analysis of cross-country collaborations in Europe. 4. International PPRI Conference 2019: Medicine access challenge - The value of pricing and reimbursement policies, 24. Oktober 2019, Wien.

Vogler, Sabine; Zimmermann, Nina; Haasis, Manuel Alexander (2019): PPRI Report 2018 - Pharmaceutical pricing and reimbursement policies in 47 PPRI network member countries. WHO Collaborating Centre for Pricing and Reimbursement Policies. Gesundheit Österreich, Wien.

Vogler, Sabine; Zimmermann, Nina; Habimana, Katharina (2014): Study of the policy mix for the reimbursement of medicinal products. Proposal for a best practice-based approach based on stakeholder assessment. Gesundheit Österreich Forschungs- und Planungs GmbH und SOGETI, Wien.

Vogler, Sabine; Zimmermann, Nina; Habl, Claudia (2015): Kostenintensive Arzneispezialitäten im europäischen Preisvergleich. Gesundheit Österreich GmbH, Wien. ISBN 978-3-85159-190-3

Vogler, Sabine; de Rooij, Roger (2018): Medication wasted – Contents and costs of medicines ending up in household garbage. Research in Social and Administrative Pharmacy, 14 (12). pp. 1140-1146.

W

Weigl, Marion; Antony, Katja (2008): Arzneimittelsysteme in Bulgarien und Rumänien. Gesundheit Österreich GmbH / Geschäftsbereich ÖBIG, Wien.

Windisch, Friederike (2018): Medical devices – future project 2018. Utrecht WHO Winter Meeting, 9. bis 10. Jänner 2018, Utrecht.

Windisch, Friederike; Haasis, Manuel Alexander; Schneider, Peter; Vogler, Sabine (2019): Preisvergleich ausgabenstarker Arzneispezialitäten 2019 - Studienprotokoll. Gesundheit Österreich, Wien.

Z

Zimmermann, Nina (2018): Evidence-based policy making in the field of pharmaceuticals - or how to better design a pharmaceutical policy? EbM Kongress, 9. März 2018, Graz.

Zimmermann, Nina (2018): Experiencia de la Red Europea para la Información sobre Regulación de Precios y Reembolso Medicamentos. Il Encuentro de Acceso, Monitoreo y Regulaciòn Econòmica del Mercado de Medicamentos, 6. November 2018, Webinar.

Zimmermann, Nina (2018): Hochpreisige Medikamente – was tut sich auf europäischer und internationaler Ebene? pharmaKON: Erstattung & Market Access, 28. November 2018, Wien.

Zimmermann, Nina (2019): Hochpreisige Medikamente – was tut sich auf europäischer und internationaler Ebene? imh PharmaKON 2019: Erstattung, 27. November 2019, Wien.

Zimmermann, Nina (2018): Interne Darstellung der pharmazeutischen Leistungen. Rolle der klinischen Pharmazie im österreichischen Gesundheitssystem. Gerinnung Interaktiv - Für Krankenhausapotheker/innen, 10. März 2018, Wien.

Zimmermann, Nina (2018): Transparency and pricing agreements. Network of Competent Authority of Pricing and Reimbursement (NCAPR) meeting, 26. September 2018, Wien.

Zimmermann, Nina (2019): The role of evidence in pharmaceutical pricing and reimbursement decisions in hospitals – in Austria and Europe. Hope Programme for Hospital and Healthcare Professionals, 7. Mai 2019, Wien.

Zimmermann, Nina; Haasis, Alexander; Balbino, Espin; Babar, Zaheer-Ud-Din; Vogler, Sabine; Busse, Reinhard; Mantel-Teeuwisse, Aukje; Suleman, Fatima (2019): Can pharmaceutical pricing and reimbursement policies make a difference in promoting equitable access to affordable medicines? Journal of Pharmaceutical Policy and Practice. ISSN 2052-3211

Zimmermann, Nina; Habimana, Katharina (2017): Arzneimittelausgaben in Österreich. Gesundheit Österreich, Vienna.

Zimmermann, Nina; Rainer, Lukas (2018): Short PPRI Pharma Profile. Gesundheit Österreich, Wien.

Zimmermann, Nina; Vogler, Sabine (2012): PPRI / PHIS Pharma Profile. Austria 2012. Gesundheit Österreich GmbH / Geschäftsbereich ÖBIG, Wien.

Zimmermann, Nina; Vogler, Sabine; Gombocz, Margit (2019): Pharmaceutical pricing and reimbursement policies – Comparative analysis in 47 PPRI member countries. 4. International PPRI Conference 2019: Medicine access challenge - The value of pricing and reimbursement policies, 24. Oktober 2019, Wien.

Zimmermann, Nina; Zuba, Martin (2018): Arzneimittelausgaben pro Kopf im internationalen Vergleich. Gesundheit Österreich, Wien.

Zuidberg, Christel; Vogler, Sabine; Mantel, A (2010): The pharmaceutical system of the Netherlands. A comparative analysis between the Dutch out-patient pharmaceutical system, in particular the pricing and reimbursement characteristics, and those of the other European Union Member States, with a special focus on tendering-like systems. Gesundheit Österreich GmbH, Wien.

This list was generated on Wed Aug 5 16:08:02 2020 CEST.